Cargando…
Author's reply. “Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: Comment”
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SEGG. Published by Elsevier España, S.L.U.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133887/ https://www.ncbi.nlm.nih.gov/pubmed/37225524 http://dx.doi.org/10.1016/j.regg.2023.04.003 |
| _version_ | 1785031653592137728 |
|---|---|
| author | Meijide Míguez, Héctor Montes García, Iñaki Ochando Gómez, Miguel García Merino, Isabel M. Cano, Emilio L. De La Torre, Alejandro |
| author_facet | Meijide Míguez, Héctor Montes García, Iñaki Ochando Gómez, Miguel García Merino, Isabel M. Cano, Emilio L. De La Torre, Alejandro |
| author_sort | Meijide Míguez, Héctor |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10133887 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | SEGG. Published by Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101338872023-04-27 Author's reply. “Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: Comment” Meijide Míguez, Héctor Montes García, Iñaki Ochando Gómez, Miguel García Merino, Isabel M. Cano, Emilio L. De La Torre, Alejandro Rev Esp Geriatr Gerontol Letter to the Editor SEGG. Published by Elsevier España, S.L.U. 2023 2023-04-27 /pmc/articles/PMC10133887/ /pubmed/37225524 http://dx.doi.org/10.1016/j.regg.2023.04.003 Text en © 2023 SEGG. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Meijide Míguez, Héctor Montes García, Iñaki Ochando Gómez, Miguel García Merino, Isabel M. Cano, Emilio L. De La Torre, Alejandro Author's reply. “Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: Comment” |
| title | Author's reply. “Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: Comment” |
| title_full | Author's reply. “Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: Comment” |
| title_fullStr | Author's reply. “Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: Comment” |
| title_full_unstemmed | Author's reply. “Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: Comment” |
| title_short | Author's reply. “Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: Comment” |
| title_sort | author's reply. “immunogenicity, effectiveness and safety of covid-19 vaccine in older adults living in nursing homes: comment” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133887/ https://www.ncbi.nlm.nih.gov/pubmed/37225524 http://dx.doi.org/10.1016/j.regg.2023.04.003 |
| work_keys_str_mv | AT meijidemiguezhector authorsreplyimmunogenicityeffectivenessandsafetyofcovid19vaccineinolderadultslivinginnursinghomescomment AT montesgarciainaki authorsreplyimmunogenicityeffectivenessandsafetyofcovid19vaccineinolderadultslivinginnursinghomescomment AT ochandogomezmiguel authorsreplyimmunogenicityeffectivenessandsafetyofcovid19vaccineinolderadultslivinginnursinghomescomment AT garciamerinoisabelm authorsreplyimmunogenicityeffectivenessandsafetyofcovid19vaccineinolderadultslivinginnursinghomescomment AT canoemiliol authorsreplyimmunogenicityeffectivenessandsafetyofcovid19vaccineinolderadultslivinginnursinghomescomment AT delatorrealejandro authorsreplyimmunogenicityeffectivenessandsafetyofcovid19vaccineinolderadultslivinginnursinghomescomment |